Abstract:Allostery is a universal, biological phenomenon in which orthosteric sites are fine-tuned by topologically distal allosteric sites triggered by perturbations, such as ligand binding, residue mutations, or post-translational modifications. Allosteric regulation is implicated in a variety of physiological and pathological conditions and is thus emerging as a novel avenue for drug discovery. Allosteric drugs have traditionally been discovered by serendipity through large-scale experimental screening. Recently, we have witnessed significant progress in biophysics, particularly in structural bioinformatics, which has facilitated the in-depth characterization of allosteric effects and the accurate detection of allosteric residues and exosites. These advances improve our understanding of allosterism and promote allosteric drug discovery, thereby revolutionizing the shift from the traditional serendipitous route used to discover allosteric drugs to the updated path centered on rational structure-based design. In this review, recent advances in computational methods applied to allosteric drug discovery are summarized. We comprehensively review these achievements along various levels of allosteric events, from the construction of allosteric databases to the identification and analysis of allosteric residues, signals, sites, and modulators. We expect to increase the awareness of the discovery of allosteric drugs using structure-based computational methods. This article is categorized under: Structure and Mechanism > Computational Biochemistry and Biophysics

Allosteric Modulation of Ligand-gated Ion Channel Receptor

Toward understanding the molecular basis for chemical allosteric modulator design

Pharmacological Development of G Protein-Coupled Receptors Allosteric Modulation

Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.

Harnessing Allostery: a Novel Approach to Drug Discovery.

Covalent allosteric modulation: An emerging strategy for GPCRs drug discovery

Protein Allostery in Drug Discovery

Molecular Insights into Ago-Allosteric Modulation of the Human Glucagon-Like Peptide-1 Receptor

Computational elucidation of allosteric communication in proteins for allosteric drug design

Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.

Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembrane interface

Allosteric Type and Pathways Are Governed by the Forces of Protein-Ligand Binding

Along the allostery stream: Recent advances in computational methods for allosteric drug discovery

Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design

The Allosteric Regulation of General Anesthetics on Protein Models and Ion Channels As Well As Their Target Sites

Research progress of indole-fused derivatives as allosteric modulators: Opportunities for drug development

Concerted Conformational Changes Control Metabotropic Glutamate Receptor Activity.

Characteristics of Allosteric Proteins, Sites, and Modulators.

Discovery of Novel Allosteric Modulators Targeting an Extra-Helical Binding Site of GLP-1R Using Structure- and Ligand-Based Virtual Screening

Vestibular Modulation by Stimulant Derivatives in a Pentameric Ligand-Gated Ion Channel

Progress in Allosteric Database